Mayo Clinic expands partnership with AI firm on disease diagnosis, treatment discovery

Rochester, Minn.-based Mayo Clinic has expanded its relationship with artificial intelligence-driven health tech company Nference to use deidentified patient data to help research and discover disease diagnoses and treatments.

Advertisement

As part of the project, the academic health system’s data analytics hub, Mayo Clinic Platform, has launched its own version of Nference’s nSights platform, called Mayo Clinic Platform_Discover. The project will allow biotech, medical device and diagnostic companies access to the EHR data, which Mayo notes is anonymous and never leaves its system.

“Over the past year, our collaboration with Nference, leveraging nSights, has accelerated clinical decision support and care in significant ways,” Mayo Clinic Platform COO Maneesh Goyal said in a Sept. 21 health system news release. “Data-derived insights and knowledge help us accelerate and enhance innovation and meet the unmet needs of patients everywhere.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.